Trademarkia Logo

Canada

C$
TOLEJI
ABANDONED SECTION 36

on 4 May 2022

Last Applicant/ Owned by

WARNER-LAMBERT COMPANY LLC

235 East 42nd StreetNew York, NY 10017

US

Serial Number

1917621 filed on 30th Aug 2018

Correspondent Address

TORYS LLP

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

CA

M5K1N2

TOLEJI

Trademark usage description

(1) pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerative nerve diseases and brain disorders, namely, moo Read More

Classification Information


Class [005]
(1) Pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerative nerve diseases and brain disorders, namely, mood, anxiety and cognitive disorders, Alzheimer's disease, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis; Pharmaceutical preparations for the prevention and treatment of cranial and facial nerve disorders, connective tissue injuries, diseases and disorders, bone and cartilage injuries, diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neuromuscular and neurological diseases and disorders, namely, central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, muscle diseases and disorders, namely inflammatory muscle diseases and disorders and muscular dystrophy, ocular motility and spinal cord infections, injuries and diseases, and seizure disorders; Pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, inflammatory pelvic, vaginitis, dysmenorrhea, cervix erosion, cervicitis, trachelitis, uterine cervicitis, endomitriosis, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence; Pharmaceutical preparations for the prevention and treatment of cardiovascular, gastrointestinal, hematologic, oncological, ophthalmological and respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders, namely collagen disease, rheumatoid arthritis, systemic lupus erythematosus, alopecia areata, and systemic sclerosis; Pharmaceutical preparations for the prevention and treatment of allergies, hypertension, menopause, diabetic neuropathy, arthritis, and pain; Antibiotics, anti-infectives, anti-inflammatories, antifungal medication, anti-virals, oral and injectable pharmaceutical contraceptives, human vaccines; Pharmaceutical preparations for the prevention and treatment of smoking habits and addictions; Pharmaceutical preparations for the prevention and treatment of renal disease and disorders; Pharmaceutical preparations for the prevention and treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the prevention and treatment of muscular atrophy; Pharmaceutical preparations for the prevention and treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, hypoglycemia, muscular dystrophy, sickle cell disease, non-alcoholic steatohepatitis and anemia; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, acne, pyoderma, skin erosion, ulcer, skin wounds, burned skin, pain and inflammation.


Classification kind code

11

Mark Details


Serial Number

1917621

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 191
on 28th Jul 2021
Registration Fee Notice Sent
Submitted for opposition 190
on 28th Jul 2021
Registration Pending
Submitted for opposition 42
on 5th May 2021
Advertised
Submitted for opposition 27
on 18th Mar 2021
Approval Notice Sent
Submitted for opposition 26
on 18th Mar 2021
Approved
Submitted for opposition 22
on 2th Dec 2020
Search Recorded
Submitted for opposition 20
on 2th Dec 2020
Examiner's First Report
Submitted for opposition 31
on 4th Sept 2018
Formalized
Submitted for opposition 1
on 31st Aug 2018
Created
Submitted for opposition 30
on 30th Aug 2018
Filed